Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Only secondary literature.

Data source

Referenceopen allclose all

Reference Type:
review article or handbook
Title:
Toxicological evaluations 14
Author:
BG Chemie
Year:
1995
Bibliographic source:
Potential Health Hazards of Exisiting Chemicals.
Reference Type:
publication
Title:
Zur Bewertung der akuten Toxizitaet einer leichthydrolysierbaren Verbindung der Chlrosulfonsaeure (Schwefelsaeurechlorid).
Author:
Mamleeva NK, and Bakhtizina GZ
Year:
1976
Bibliographic source:
Tr Mosk NII Gigieny 9, 110-113.
Reference Type:
review article or handbook
Title:
Chlorosulfonic Acid
Author:
HSDB
Year:
2010
Bibliographic source:
National Library of Medicine (NLM, http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB)

Materials and methods

Principles of method if other than guideline:
The acute inhalation toxicity (LC50) of chlorosulphuric acid was studied in white rats. Rats were exposed once for 4 hours.
GLP compliance:
no
Remarks:
GLP was not mandatory at the time of the study.
Test type:
standard acute method

Test material

Constituent 1
Chemical structure
Reference substance name:
Chlorosulphuric acid
EC Number:
232-234-6
EC Name:
Chlorosulphuric acid
Cas Number:
7790-94-5
Molecular formula:
ClHO3S
IUPAC Name:
sulfurochloridic acid
Details on test material:
- Name of test material (as cited in study report): chlorosulfonic acid.
- Analytical purity: not reported.

Test animals

Species:
rat
Sex:
not specified

Administration / exposure

Route of administration:
inhalation
Details on inhalation exposure:
The study was repeated on several occasions because of possible hydrolysis of the substance in the inhalation chamber. The air was dried prior to entering to the chamber, but a persistent slight mist could still be observed.
Analytical verification of test atmosphere concentrations:
no
Duration of exposure:
4 h
Concentrations:
16.0-92.4 mg/m³
No. of animals per sex per dose:
no data.
Control animals:
other: not necessary

Results and discussion

Effect levels
Sex:
not specified
Dose descriptor:
LC50
Effect level:
38.5 mg/m³ air
Exp. duration:
4
Clinical signs:
other: Clinical symptoms included severe irritation of the respiratory tract and eyes, a staggering gait, staining of the coat and clonic spasm.
Gross pathology:
Post-mortem examinations revealed hyperaemia of the lung and the liver and, in animals exposed to concentrations greater than the LC50, pulmonary oedema.
Other findings:
- Organ weights: the relative weights of the liver and lungs were increased in the rats and the relative spleen weights were decreased.
- Histopathology: histological examination revealed congestion of the internal organs, severe irritation of the tracheobronchial system and hyperaemia of the brain and meninges, with perivascular and pericellular oedema and swelling of the ganglion cells. Focal haemorrhages of the myocardium, with swelling and necrobiosis of individual myofibrils, were observed. In the liver, fatty degeneration of the hepatocytes, necrobiotic foci and structural breakdown of the liver canals were found. The kidneys showed effects suggestive of toxic nephrosis.

Applicant's summary and conclusion